However, it is known that treatment with Hsp90 inhibitors leads, through a negative feedback loop, to activation of the heat shock factor (HSF1), which causes transcriptional induction of Hsp70/Hsp27 that protect cancer cells from apoptosis and induce drug resistance [6, 7], offsetting their own anticancer activities. This evidence concerns the gene HSF1 and cancer.